Abcodia Suspends Sale of Ovarian Cancer Screening Test After FDA Communication

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Abcodia Inc., a British company that manufactures a controversial ovarian cancer screening test, said it will temporarily suspend the availability of the product in the United States.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Laura Brawley
Laura Brawley
Table of Contents

YOU MAY BE INTERESTED IN

An updated version of President Trump’s budget request published on May 2 comes as a disappointment for those who hoped that the White House would rethink the draconian cuts contained in an earlier, confidential version of the document that ended up being leaked to the press. 
Laura Brawley
Laura Brawley

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login